- Home
- GUG vs QTRX Comparison
GUG vs QTRX Comparison
Compare GUG & QTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GUG
- QTRX
- Stock Information
- Founded
- GUG 2021
- QTRX 2007
- Country
- GUG United States
- QTRX United States
- Employees
- GUG N/A
- QTRX N/A
- Industry
- GUG Trusts Except Educational Religious and Charitable
- QTRX Biotechnology: Laboratory Analytical Instruments
- Sector
- GUG Finance
- QTRX Industrials
- Exchange
- GUG Nasdaq
- QTRX Nasdaq
- Market Cap
- GUG 507.2M
- QTRX 439.1M
- IPO Year
- GUG N/A
- QTRX 2017
- Fundamental
- Price
- GUG $15.29
- QTRX $11.31
- Analyst Decision
- GUG
- QTRX Strong Buy
- Analyst Count
- GUG 0
- QTRX 4
- Target Price
- GUG N/A
- QTRX $23.25
- AVG Volume (30 Days)
- GUG 108.9K
- QTRX 332.4K
- Earning Date
- GUG 01-01-0001
- QTRX 11-12-2024
- Dividend Yield
- GUG 9.67%
- QTRX N/A
- EPS Growth
- GUG N/A
- QTRX N/A
- EPS
- GUG N/A
- QTRX N/A
- Revenue
- GUG N/A
- QTRX $129,330,000.00
- Revenue This Year
- GUG N/A
- QTRX $13.89
- Revenue Next Year
- GUG N/A
- QTRX $15.51
- P/E Ratio
- GUG N/A
- QTRX N/A
- Revenue Growth
- GUG N/A
- QTRX 15.52
- 52 Week Low
- GUG $12.71
- QTRX $10.29
- 52 Week High
- GUG $15.06
- QTRX $29.70
- Technical
- Relative Strength Index (RSI)
- GUG 33.47
- QTRX 42.33
- Support Level
- GUG $15.43
- QTRX $10.29
- Resistance Level
- GUG $15.79
- QTRX $12.35
- Average True Range (ATR)
- GUG 0.22
- QTRX 0.67
- MACD
- GUG -0.04
- QTRX -0.08
- Stochastic Oscillator
- GUG 12.86
- QTRX 30.33
About GUG Guggenheim Active Allocation Fund of Beneficial Interest
Guggenheim Active Allocation Fund is a diversified closed-end management investment company. The fund's investment objective is to maximize total return through a combination of current income and capital appreciation. The company invests in both fixed-income and other debt instruments selected from a variety of sectors and credit qualities, and may also invest in equities. It uses tactical asset allocation models to determine the optimal allocation of its assets between fixed-income and equity securities. A majority of its investments are made in corporate bonds and the rest in senior floating rate interests, asset-backed securities, preferred stocks, and other securities.
About QTRX Quanterix Corporation
Quanterix Corp is a life sciences company. It focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory, Homebrew - Custom Assay Development, and Uman NF-Light.